
Онлайн книга «Мифы о диетах. Наука о том, что мы едим»
17. Daneman, N., Lancet (12 Oct 2013); 382 (9900): 1228–30. A probiotic trial: tipping the balance of evidence? 18. Guo, Z., Nutr Metab Cardiovasc Dis (2011); 21: 844–50. Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials. 19. Jones, M.L., Br J Nutr (May 2012); 107 (10): 1505–13. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. 20. Jones, M.L., Eur J Clin Nutr (2012); 66: 1234–41. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. 21. Morelli, L., Am J Clin Nutr (2014); 99 (suppl): 1248S–50S. Yogurt, living cultures, and gut health. 22. McNulty, N.P., Sci Transl Med (26 Oct 2011); 3: 106. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. 23. Goodrich, J.K., Cell (6 Nov 2014); 159 (4): 789–99. Human genetics shape the gut microbiome. 24. Roederer, M., The Genetic Architecture of the Human Immune System (Cell, 2015). 25. Saulnier, D.M., Gut Microbes (Jan–Feb 2013); 4 (1): 17–27. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. 26. De Palma, G., Gut Microbes (May–Jun 2014); 5 (3): 439–45. The microbiota-gut-brain axis in functional gastrointestinal disorders. 27. Sachdev, A.H., Curr Gastroenterol Rep (Oct 2012); 14 (5): 439–45. Antibiotics for irritable bowel syndrome. 28. Roederer, M., The Genetic Architecture of the Human Immune System (Cell, 2015). 29. Tillisch, K., Gastroenterology (Jun 2013); 144 (7): 1394–401. Consumption of fermented milk product with probiotic modulates brain activity. 30. Tillisch, K., Gut Microbes (May–Jun 2014); 5 (3): 404–10. The effects of gut microbiota on CNS function in humans. 5. Жиры ненасыщенные 1. В стихотворении также может идти речь об увеличении налогов (непопулярной мере Карла I и Генриетты-Марии) или даже о более раннем споре между королем Ричардом и его братом Джоном. 2. Daniel, C.R., Public Health Nutr (Apr 2011); 14 (4): 575–83. Trends in meat consumption in the United States. 3. http://www.eblex.org.uk/wp/wp-content/uploads/2014/02/m_uk_yearbook13_Cattle110713.pdf. 4. Micha, R., Lipids (Oct 2010); 45 (10): 893–905. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. 5. Siri-Tarino, P.W., Am J Clin Nutr (2010); 91: 535–46. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. 6. Price, W.A., Nutrition and Physical Degeneration, 6th edn (La Mesa, Ca, Price-Pottenger Nutritional Foundation, 2003). 7. Willett, W.C., Am J Clin Nutr (Jun 1995); 61 (6 Suppl): 1402S–6S. Mediterranean diet pyramid: a cultural model for healthy eating. 8. Estruch, R., N Engl J Med (4 Apr 2013); 368 (14): 1279–90. Primary prevention of cardiovascular disease with a Mediterranean diet. 9. Salas-Salvadó, J., Ann Intern Med (7 Jan 2014); 160 (1): 1–10. Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial. 10. Guasch-Ferré, M., BMC Med (2014); 12: 78. Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study. 11. Konstantinidou, V., FASEB J (Jul 2010); 24 (7): 2546–57. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. 12. Lanter, B.B., MBio (2014); 5 (3): e01206–14. Bacteria present in carotid arterial plaques are found as biofilm deposits which may contribute to enhanced risk of plaque rupture. 13. Vallverdú-Queralt, A., Food Chem (15 Dec 2013); 141 (4): 3365–72. Bioactive compounds present in the Mediterranean sofrito. 6. Трансжиры 1. https://www.youtube.com/watch?v=zrv78nG9R04. 2. Lam, H.M., Lancet (8 Jun 2013); 381 (9882): 2044–53. Food supply and food safety issues in China. 3. Mozaffarian, D., N Engl J Med (2006); 354: 1601–13. Trans fatty acids and cardiovascular disease. 4. Kris-Etherton, P.M., Lipids (Oct 2012); 47 (10): 931–40. Trans fatty acid intakes and food sources in the U.S. population: NHANES 1999–2002. 5. Thomas, L.H., Am J Clin Nutr (1981); 34: 877–86. Hydrogenated oils and fats: the presence of chemically-modified fatty acids in human adipose tissue. 6. Iqbal, M.P., Pak J Med Sci (Jan 2014); 30 (1): 194–7. Trans fatty acids — a risk factor for cardiovascular disease. 7. Kishino, S., Proc Natl Acad Sci (29 Oct 2013); 110 (44): 17808–13. Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition. 8. Pacifico, L., World J Gastroenterol (21 Jul 2014); 20 (27): 9055–71. Nonalcoholic fatty liver disease and the heart in children and adolescents. 9. Mozaffarian, D., N Engl J Med (3 Jun 2011); 364 (25): 2392–404. Changes in diet and lifestyle and long-term weight gain in women and men. 11. Moss, M., Salt, Sugar, Fat: How the Food Giants Hooked Us (WH Allen, 2013). 12. Johnson, P.M., Nat Neurosci (May 2010); 13 (5): 635–41. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. 13. Avena, N.M., Methods Mol Biol (2012); 829: 351–65. Animal models of sugar and fat bingeing: relationship to food addiction and increased body weight. 14. Taylor, V.H., CMAJ (9 Mar 2010); 182 (4): 327–8. The obesity epidemic: the role of addiction. |